Regeneron Pharmaceuticals Inc (1REGN)
BIT
The current 1REGN market cap is 84.46B. The company's latest EPS is USD 35.8654 and P/E is 23.11.
Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|
USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
Total Revenue | 7.86B | 8.78B | 16.12B | 12.26B | 13.12B |
Operating Income | 2.21B | 3.58B | 8.95B | 4.74B | 4.05B |
Net Income | 2.12B | 3.51B | 8.08B | 4.34B | 3.95B |
Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|
USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
Total Assets | 14.81B | 17.16B | 25.43B | 29.21B | 33.08B |
Total Liabilities | 3.72B | 6.14B | 6.67B | 6.55B | 7.11B |
Total Equity | 11.09B | 11.03B | 18.77B | 22.66B | 25.97B |
Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|
USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
Operating | 2.43B | 2.62B | 7.08B | 5.01B | 4.59B |
Investing | -2.03B | -70.6M | -5.38B | -3.78B | -3.19B |
Financing | -252.1M | -1.97B | -1.01B | -1.01B | -1.79B |
Market Cap | 84.46B |
Price to Earnings Ratio | 23.11 |
Price to Sales Ratio | 6.96 |
Price to Cash Ratio | 33.47 |
Price to Book Ratio | 3.52 |
Dividend Yield | - |
Shares Outstanding | 110.23M |
Average Volume (1 week) | 25 |
Average Volume (1 Month) | 20 |
52 Week Change | 4.96% |
52 Week High | 1,094.50 |
52 Week Low | 730.00 |
Spread (Intraday) | 7.2 (0.94%) |
Company Name | Regeneron Pharmaceuticals Inc |
Address |
28 liberty street new york, new york 10005 |
Website | https://www.regeneron.com |
Industry | health care diversified (H) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.